Applied Dna Sciences
Open
$0.51
Prev. Close
$0.51
High
$0.52
Low
$0.51
Market Snapshot
$2.23M
-0.0
629.08
$2.76M
26
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
emptyResult
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Recently from Cashu
It seems you're asking for a specific text to summarize, but I don't see the content you want condensed. Please share the content, and I'll help create a title for you!
Please provide the text you'd like summarized, and I'll be happy to help!
Applied DNA Sciences: Leading DNA Innovations for Enhanced Supply Chain Security and Authenticity
Applied DNA Sciences: Pioneering Innovations in DNA-Based Security Solutions Applied DNA Sciences, a leader in DNA-based security solutions, focuses on enhancing supply chain integrity through its inn…
Applied DNA Sciences Expands Partnerships to Strengthen Supply Chain Security Solutions
Applied DNA Sciences Expands Strategic Partnerships to Enhance Supply Chain Security Applied DNA Sciences, a leader in DNA-based supply chain security solutions, is set to strengthen its market positi…
Applied DNA Sciences: Innovative Solutions and Advancements in DNA-Based Technology
Sure! Please provide the text you would like me to summarize into a 300-word paragraph.